EVGN · Evogene Ltd.
Market Cap
$8.68M
Shares
15.80M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.85M
-30.9%
FY2025
Net Income
-$8.49M
+48.5%
FY2025
Gross Margin
-6.25%
-63.6pp
FY2025
Operating Margin
-364.24%
-27.1pp
FY2025
Diluted EPS
$1.08
+137.2%
FY2025
Operating Cash Flow
-$13.5M
+31.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.85M | $5.58M | $2.98M | $1.68M | $930K | $1.04M | $753K | $1.75M | $3.38M | $6.54M | $11.13M | |
| $4.09M | $2.38M | $1.49M | $909K | $767K | $574K | $334K | $1.45M | $2.85M | $5.64M | $8.26M | |
| -$241K | $3.2M | $1.49M | $766K | $163K | $466K | $419K | $295K | $536K | $901K | $2.87M | |
| -6.25% | 57.32% | 50.03% | 45.73% | 17.53% | 44.81% | 55.64% | 16.89% | 15.85% | 13.78% | 25.82% | |
| $7.99M | $12.51M | $16.2M | $20.79M | $21.13M | $17.29M | $15.79M | $14.69M | $16.99M | $16.41M | $14.45M | |
| $1.48M | $1.98M | $2.15M | $3.93M | $2.74M | $2.67M | — | — | — | — | — | |
| $522K | $579K | $658K | — | — | — | — | $161K | $309K | $599K | $960K | |
| -$14.03M | -$18.8M | -$22.23M | -$26.94M | -$30.95M | -$24.81M | -$21.17M | -$19.99M | -$21.95M | -$21.09M | -$17.92M | |
| -364.24% | -337.17% | -745.51% | -1608.42% | -3328.28% | -2385.96% | -2810.89% | -1144.19% | -649.13% | -322.46% | -161.03% | |
| -$13.51M | -$18.23M | -$21.57M | — | — | — | — | -$19.83M | -$21.64M | -$20.49M | -$16.96M | |
| $1.93M | $3.36M | $928K | $3.33M | $1.41M | $2.95M | $555K | $2.21M | $1.01M | $891K | $1.86M | |
| -$13.5M | -$14.81M | -$21.95M | -$29.75M | -$30.43M | -$26.17M | -$19.09M | -$20.78M | -$20.83M | -$19.56M | -$17.21M | |
| $1000 | $9000 | $19K | $90K | $13K | $32K | $24K | $30K | $11K | $36K | — | |
| -$8.49M | -$16.49M | -$23.88M | -$26.64M | -$27.79M | -$23.37M | -$18.11M | -$20.76M | -$20.84M | -$19.59M | -$17.21M | |
| -220.22% | -295.59% | -800.77% | -1590.33% | -2988.49% | -2247.5% | -2405.31% | -1188.21% | -616.33% | -299.57% | -154.67% | |
| USD/shares | $1.08 | -$2.90 | -$5.20 | -$6.44 | -$6.90 | -$8.30 | — | — | — | — | — |
| USD/shares | $1.08 | -$2.90 | -$5.20 | -$6.44 | -$6.90 | -$8.30 | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.